The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Transcriptomic heterogeneity of androgen receptor activity in primary prostate cancer: Identification and characterization of a low AR-active subclass.
 
Daniel Eidelberg Spratt
No Relationships to Disclose
 
Mohammed Alshalalfa
Employment - GenomeDx
 
Adam Weiner
No Relationships to Disclose
 
Nick Fishbane
Employment - GenomeDx
 
Rohit Mehra
No Relationships to Disclose
 
Rayford Walter
No Relationships to Disclose
 
Nicholas Erho
Employment - GenomeDx
 
Adam Dicker
Consulting or Advisory Role - EMD Serono; Ferring; Janssen; RedHill Biopharma
Travel, Accommodations, Expenses - Ferring; Merck KGaA
Other Relationship - Department of Defense-Prostate Cancer Research Program; NRG Oncology
 
Stephen J. Freedland
Stock and Other Ownership Interests - Armune Bioscience; Parallel6
Consulting or Advisory Role - Armune Bioscience; Astellas Pharma; Bayer; Dendreon; GenomeDx; Janssen Biotech; MDxHealth; Medivation; Parallel6; Sanofi
Research Funding - Amgen (Inst); Bayer (Inst); Dendreon (Inst); GenomeDx (Inst); Janssen Biotech (Inst); MDxHealth (Inst); Metabolon (Inst); Mitomics (Inst); Myriad Genetics (Inst); OPKO Diagnostics (Inst); POM Wonderful (Inst); Progenika (Inst)
Travel, Accommodations, Expenses - GenomeDx; Myriad Genetics; Sanofi
 
Jeffrey Karnes
No Relationships to Disclose
 
Andrew Glass
No Relationships to Disclose
 
Sheila Weinmann
No Relationships to Disclose
 
Elai Davicioni
Employment - GenomeDx
Leadership - GenomeDx
Stock and Other Ownership Interests - GenomeDx
Patents, Royalties, Other Intellectual Property - CANCER DIAGNOSTICS USING BIOMARKERS 20140066323
Travel, Accommodations, Expenses - GenomeDx
 
Ashley Ross
Stock and Other Ownership Interests - GenomeDx
Honoraria - Healthtronics
Consulting or Advisory Role - Healthtronics
Research Funding - metamark genetics
 
Robert Benjamin Den
Consulting or Advisory Role - GenomeDx
Speakers' Bureau - Bayer
Research Funding - GenomeDx; Medivation/Astellas
Travel, Accommodations, Expenses - GenomeDx
 
Felix Y Feng
Leadership - PFS Genomics
Stock and Other Ownership Interests - PFS Genomics
Consulting or Advisory Role - Celgene; Dendreon; EMD Serono; Ferring; GenomeDx; Janssen Oncology; Medivation/Astellas; Sanofi
Research Funding - Celgene; Varian Medical Systems
Patents, Royalties, Other Intellectual Property - I helped develop a molecular signature to predict radiation resistance in breast cancer, and this signature was patented by the University of Michigan, my employer. It is in the process of being licensed to PFS Genomics, a company that I helped found. (Inst)
 
Edward M. Schaeffer
Consulting or Advisory Role - OPKO Diagnostics